MedPath
HSA Approval

RASPUTIN SOFT CAPSULE 0.25 mcg

SIN12258P

RASPUTIN SOFT CAPSULE 0.25 mcg

RASPUTIN SOFT CAPSULE 0.25 mcg

April 25, 2003

SHOEI UNIVERSAL CORPORATION PTE LTD

SHOEI UNIVERSAL CORPORATION PTE LTD

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantSHOEI UNIVERSAL CORPORATION PTE LTD
Licence HolderSHOEI UNIVERSAL CORPORATION PTE LTD

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Prescription Only
HSA Singapore Classification

Formulation Information

CAPSULE, LIQUID FILLED

ORAL

Medical Information

A11CC04

calcitriol

Manufacturer Information

SHOEI UNIVERSAL CORPORATION PTE LTD

YOUNG IL PHARM CO LTD

Hanmi Pharmaceuticals

Active Ingredients

CALCITRIOL

0.25 mcg

Calcitriol

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

RASPUTIN SOFT CAPSULE 0.25 mcg - HSA Approval | MedPath